269 related articles for article (PubMed ID: 11087432)
1. A comprehensive structural analysis of hemoglobin adducts formed after in vitro exposure of erythrocytes to butadiene monoxide.
Moll TS; Harms AC; Elfarra AA
Chem Res Toxicol; 2000 Nov; 13(11):1103-13. PubMed ID: 11087432
[TBL] [Abstract][Full Text] [Related]
2. Advances in the mass spectrometry of hemoglobin adducts: global analysis of the covalent binding of butadiene monoxide.
Moll TS; Harms AC; Elfarra AA
Chem Biol Interact; 2001 Jun; 135-136():667-74. PubMed ID: 11397420
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the reactivity, regioselectivity, and stereoselectivity of the reactions of butadiene monoxide with valinamide and the N-terminal valine of mouse and rat hemoglobin.
Moll TS; Elfarra AA
Chem Res Toxicol; 1999 Aug; 12(8):679-89. PubMed ID: 10458701
[TBL] [Abstract][Full Text] [Related]
4. A liquid chromatography tandem mass spectrometric method for in vivo dose monitoring of diepoxybutane, a metabolite of butadiene.
Kautiainen A; Fred C; Rydberg P; Törnqvist M
Rapid Commun Mass Spectrom; 2000; 14(19):1848-53. PubMed ID: 11006595
[TBL] [Abstract][Full Text] [Related]
5. Mass spectral analyses of hemoglobin adducts formed after in vitro exposure of erythrocytes to hydroxymethylvinyl ketone.
Barshteyn N; Krause RJ; Elfarra AA
Chem Biol Interact; 2007 Mar; 166(1-3):176-81. PubMed ID: 16735035
[TBL] [Abstract][Full Text] [Related]
6. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
7. Adducts of N-terminal valines in hemoglobin with isoprene diepoxide, a metabolite of isoprene.
Fred C; Cantillana T; Henderson AP; Golding BT; Törnqvist M
Rapid Commun Mass Spectrom; 2004; 18(18):2177-84. PubMed ID: 15378724
[TBL] [Abstract][Full Text] [Related]
8. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Boysen G; Georgieva NI; Upton PB; Jayaraj K; Li Y; Walker VE; Swenberg JA
Cancer Res; 2004 Dec; 64(23):8517-20. PubMed ID: 15574756
[TBL] [Abstract][Full Text] [Related]
9. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
Fred C; Grawé J; Törnqvist M
Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous analysis of hemoglobin adducts of acrylamide and glycidamide by gas chromatography-mass spectrometry.
Pérez HL; Cheong HK; Yang JS; Osterman-Golkar S
Anal Biochem; 1999 Oct; 274(1):59-68. PubMed ID: 10527497
[TBL] [Abstract][Full Text] [Related]
12. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
[TBL] [Abstract][Full Text] [Related]
13. Adducts to N-terminal valines in hemoglobin from butadiene metabolites.
Rydberg P; Magnusson AL; Zorcec V; Granath F; Törnqvist M
Chem Biol Interact; 1996 Sep; 101(3):193-205. PubMed ID: 8870688
[TBL] [Abstract][Full Text] [Related]
14. Studies on the methyl isocyanate adducts with globin.
Mráz J; Simek P; Chvalová D; Nohová H; Smigolová P
Chem Biol Interact; 2004 Jun; 148(1-2):1-10. PubMed ID: 15223351
[TBL] [Abstract][Full Text] [Related]
15. Mass spectral analyses of hydroxymethylvinyl ketone-hemoglobin adducts formed after in vivo exposure of Sprague-Dawley rats to 3-butene-1,2-diol.
Barshteyn N; Elfarra AA
Chem Res Toxicol; 2009 Jun; 22(6):1163-71. PubMed ID: 19419228
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glycidol-hemoglobin adducts as biomarkers of exposure and in vivo dose.
Honda H; Törnqvist M; Nishiyama N; Kasamatsu T
Toxicol Appl Pharmacol; 2014 Mar; 275(3):213-20. PubMed ID: 24467927
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene.
Begemann P; Srám RJ; Neumann HG
Arch Toxicol; 2001 Jan; 74(11):680-7. PubMed ID: 11218044
[TBL] [Abstract][Full Text] [Related]
18. Exposure profiling of reactive compounds in complex mixtures.
Goel S; Evans-Johnson JA; Georgieva NI; Boysen G
Toxicology; 2013 Nov; 313(2-3):145-150. PubMed ID: 23219592
[TBL] [Abstract][Full Text] [Related]
19. Analyses of (1-chloroethenyl)oxirane headspace and hemoglobin N-valine adducts in erythrocytes indicate selective detoxification of (1-chloroethenyl)oxirane enantiomers.
Hurst HE; Ali MY
Chem Biol Interact; 2007 Mar; 166(1-3):332-40. PubMed ID: 16750522
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin adduct levels in rat and mouse treated with 1,2:3,4-diepoxybutane.
Fred C; Kautiainen A; Athanassiadis I; Törnqvist M
Chem Res Toxicol; 2004 Jun; 17(6):785-94. PubMed ID: 15206899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
